glp 1 for lupus Glucagon-like peptide and its receptor agonists the treatment of rheumatic diseases Do SGLT2 and GLP-1 therapies
Description
At the VCU Health Medical Weight Loss Program, patients are monitored carefully to make sure they continue to adequately nourish themselves and continue to develop a healthier lifestyle
JAMA Ophthalmol [Internet]
Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor triple agonist
JACC Cardiovasc Imaging 11:577585
Tobar et al., 2023)
Efficacy and safety of Once-Weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-Week, Open-Label, randomized clinical trial
